No Detail Found!

Insilico modeling and analysis of small molecules binding to the PHLPP1 protein by molecular dynamics simulation

Author(s)
Tehreem Anwar Department of Bioinformatics and Computational Biology, Virtual University of Pakistan,Lahore,Pakistan
Mirza Jawad Ul Hasnain Department of Bioinformatics and Computational Biology, Virtual University of Pakistan,Lahore,Pakistan
Amina Sarwar Department of Bioinformatics and Computational Biology, Virtual University of Pakistan,Lahore,Pakistan
Hajra Kanwal Department of Bioinformatics and Computational Biology, Virtual University of Pakistan,Lahore,Pakistan
Bakhtawar Afzal Department of Biosciences, COMSATS University,Islamabad,Pakistan
Masroor Ellahi Babar Department of Genetics, Virtual University of Pakistan,Lahore,Pakistan
Muhammad Tariq Parvez Department of Bioinformatics and Computational Biology, Virtual University of Pakistan,Lahore,Pakistan
Abstract
The PHLPP (Pleckstrin homology domain leucine-rich repeat protein phosphatases) is a newly discovered group of genes which includes PHLPP1 and PHLPP2 and plays an integral part in several cellular processes like apoptosis, cell signaling cell survival, and cell proliferation etc. Both the activation and deactivation of these genes can have vital role in several ailments like heart diseases, circadian rhythm and most importantly the cancer, hence encouraging the growth of novel therapeutic elements. To give new directions into the development of PHLPP1targeting drugs, the interaction mechanism between PHLPP1 and five important ligands 4IP, B39, 635, ATP and GTA were investigated through docking and Molecular Dynamics Simulation. It is also noteworthy to be mentioned here that there is no previous crystal structure of PHLPP1 available. The in-silico results can provide potential base for advancements in development of new therapeutic elements targeting different diseases, mainly cancer. In this study, we employed homology modeling technique to develop a high-quality structure model of PHLPP1. The PHLPP1 model was then used in docking interaction analysis and Molecular Dynamics Simulation, to study binding pockets and interactions of PHLPP1 ligands and finding actively contributing residues in binding pocket. In final step, Free Energy Estimation was performed to observe ligand binding's quantitative characteristics.
Publication Details
Page(s) 287-294
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP1, Year: 2020

Request the full text from PASTIC

Keywords
PHLPP1, Homology modeling, Phosphorylation, Cancer, Molecular Dynamics, molecular docking
References
Baffi TR,Van AN,Zhao W,Mills GB,Newton AC,Kinase C Quality AC .2019 .Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer. Mol. Cell, 74(2) : 378-392.
Newton Brognard J,AC Brognard J .2008 .PHLiPPing the switch on Akt and protein kinase C signaling. Trends. Endocrinol. Metab., 19(6) : 223-230.
Brognard J¸ Sierecki E,Gao T,Newton AC .2007 .PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell., 25(6) : 917-931.
Burley SK .2018 .Ligand validation for the protein data bank. Acta Cryst., 74(1) : 323.
Chen M,Pratt CP,Zeeman ME,Schultz N,Taylor BS,O'Neill A,Castillo-Martin M,Nowak DG,Naguib A,Grace DM,Murn J,Navin N,Atwal GS,Sander C,Gerald WL,Cordon-Cardo C,Newton AC,Carver BS,Trotman LC .2011 .Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell, 20(2) : 173-186.
Yeates TO Colovos C .1993 .Verification of protein structures: patterns of nonbonded atomic interactions. Protein Science: A Publication of the Protein Society, 2(9) : 1511-1519.
Dallakyan S,Olson AJ .2015 .Small-molecule library screening by docking with PyRx. Methods. Mol. Biol, 1263 : 243-250.
Dong X,Yang Z X .2011 .Improving the Physical Realism and Structural Accuracy of Protein Models by a Two-step Atomic-level Energy Minimization. Biophysical Journal, 101(10) : 2525-2534.
Gao T,Furnari F,Newton AC .2005 .PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis and suppresses tumor growth. Mol. Cell., 18(1) : 13-24.
Gentile F,Deriu MA,Licandro G,Prunotto A,Danani A,Tuszynski JA .2015 .Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations. , 20(5) : 8316-8340.
Humphrey W,Dalke A,Schulten K A .1996 .Visual molecular dynamics. J. Mol. Graph, 14(1) : 33-38.
Jiménez J,Skalic M,Martinez-Rosell G,De Fabritiis G G .2018 .KDEEP: Protein-Ligand Absolute Binding Affinity Prediction via 3D-Convolutional Neural Networks. J. Chem, 58(2) : 287-296.
Karnoub AE,Dash AB,Vo AP,Sullivan A,Brooks MW,Bell GW,Richardson AL,Polyak K,Tubo R,Weinberg RA .2007 .Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature, 449(7162) : 557-563.
Katsenelson KC,Stender JD,Kawashima AT,Lorden G,Uchiyama S,Nizet V,Glass CK,Newton AC .2019 .PHLPP1 counter-regulates STAT1-mediated inflammatory signaling. Elife, 8 : e48609.
Laskowski RA,MacArthur MW,Moss DS,Thornton JM .1993 .PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr., 26(2) : 283-291.
Li X,Stevens PD,Yang H,Gulhati P,Wang W,Evers BM,Gao T .2013 .The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer. Oncogene, 32(4) : 471-478.
Liu J,Weiss HL,Rychahou P,Jackson LN,Evers BM,Gao T .2009 .Loss of PHLPP expression in colon cancer: Role in proliferation and tumorigenesis. Oncogene, 28(7) : 994-1004.
Maehama T,Dixon JE .1998 .The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger. J Biol Chem., 273(22) : 13375-13378.
Majumder PK,Yeh JJ,George DJ,Febbo PG,Kum J,Xue Q,Bikoff R,Ma H,Kantoff PW,Golub TR,Loda M,Sellers WR M .2003 .Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc. Natl. Acad. Sci. USA, 100(13) : 7841-7846.
Patael-Karasik Y,Daniely M,Gotlieb WH,Ben-Baruch G,Schiby J,Barakai G,Goldman B,Aviram A,Friedman E .2000 .Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel. Cancer. Genet, 121(1) : 26-32.
Rakha EA,Green AR,Powe DG,Roylance R,Ellis IO .2006 .Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosomes Cancer, 45(6) : 527-535.
Talantov D,Mazumder A,Yu JX,Briggs T,Jiang Y,Backus J,Atkins D,Wang Y .2005 .Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer. Res., 11(20) : 7234-7242.
Taylor BS,Schultz N,Hieronymus H,Gopalan A,Xiao Y,Carver BS,Arora VK,Kaushik P,Cerami E,Reva B,Antipin Y,Mitsiades N,Landers T,Dolgalev I,Major JE,Wilson M,Socci ND,Lash AE,Heguy A,Eastham JA,Scher HI,Reuter VE,Scardino PT,Sander C,Sawyers CL,Gerald WL .2010 .Integrative genomic profiling of human prostate cancer. Cancer Cell, 18(1) : 11-22.
Vyas VK,Ukawala RD,Ghate M,Chintha C M .2012 .Homology modeling a fast tool for drug discovery: Current perspectives. Indian J. Pharm. Sci., 74(1) : 1-17.
Wallace AC,Laskowski RA,Thornton JM .1995 .LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein. Eng., 8(2) : 127-134.
Waterhouse A,Bertoni M,Bienert S,Studer G,Tauriello G,Gumienny R,Heer FT,de Beer TAP,Rempfer C,Bordoli L,Lepore R,Schwede T .2018 .SWISSMODEL: homology modelling of protein structures and complexes. Nucleic Acids Res, 46(1) : 296-303.
Wong KK,Engelman JA,Cantley LC .2010 .Targeting the PI3K signaling pathway in cancer. Curr. Opin. Genet, 20(1) : 87-89.
Yan R,Chuang HC,Kapuriya N,Chou CC,Lai PT,Chang HW,Yang CN,Kulp SK,Chen CS .2015 .Exploitation of the ability of γ-tocopherol to facilitate membrane co-localization of Akt and PHLPP1 to develop PHLPP1-targeted Akt inhibitors. J Med, 58(5) : 2290-2298.
Yang J,Cron P,Thompson V,Good VM,Hess D,Hemmings BA,Barford D BA .2002 .Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell., 9(6) : 1227-1240.
0

Citations

0

Downloads

10

Views